Literature DB >> 10149701

Management of retinal vein occlusion.

L T Laatikainen1.   

Abstract

Recent research into the relationship between retinal venous occlusion and general vascular disorders has shown that retinal venous occlusion seems to be related only to systemic hypertension. The role of systemic hemorrheologic parameters in the pathophysiology of venous occlusion is a controversial one. Of the various treatment modalities, isovolemic hemodilution has been found to improve retinal perfusion, but the treatment must be repeated about once a week for at least 2 months. The presence of tissue hypoxia in areas of ischemic venous occlusion has been confirmed by measurements of preretinal oxygen pressure in experimental venous occlusion. Reduced preretinal oxygen pressure in these experimental cases normalized after retinal scatter photocoagulation. The inhibiting role of posterior vitreous detachment on posterior segment neovascularization and the fact that panretinal photocoagulation has a better effect on anterior than on posterior segment neovascularization have been evaluated in clinical studies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 10149701     DOI: 10.1097/00055735-199206000-00012

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  2 in total

1.  Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion.

Authors:  M Paques; J N Vallée; D Herbreteau; A Aymart; P Y Santiago; F Campinchi-Tardy; D Payen; J J Merlan; A Gaudric; P Massin
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

Review 2.  Systematic analysis of hydroxyethyl starch (HES) reviews: proliferation of low-quality reviews overwhelms the results of well-performed meta-analyses.

Authors:  Christiane S Hartog; Helga Skupin; Charles Natanson; Junfeng Sun; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2012-07-13       Impact factor: 17.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.